The Clinical Outcome in AChR-Positive Generalized Myasthenia Gravis: A Retrospective Observational Study

BACKGROUND: Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, and in over 80% of cases, antibodies are identified against the nicotinic type of acetylcholine receptor (AChR) on the muscle endplate. Despite the availability of various treatment options, patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojha, Pawan T., Gaikwad, Abhijeet M., Singh, Rakesh, Jagiasi, Kamlesh, Nagendra, Shashank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645268/
https://www.ncbi.nlm.nih.gov/pubmed/37970279
http://dx.doi.org/10.4103/aian.aian_186_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645268/
https://www.ncbi.nlm.nih.gov/pubmed/37970279
http://dx.doi.org/10.4103/aian.aian_186_23

Ejemplares similares